Bayer introduces medication for chronic kidney disease
PTI, Aug 26, 2022, 11:38 AM IST
Credit: iStock Photo
Drugmaker Bayer on Thursday said it has introduced a medication for the treatment of chronic kidney disease associated with diabetes under the brand name Kerendia.
The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease associated with type 2 diabetes.
“The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. Despite therapy, these patients often progress to kidney failure.
“Finerenone (Kerendia) therefore offers a new treatment approach for these vulnerable patients to slow down the progression of chronic kidney disease and reduce the risk of kidney failure,” Bayer Zydus Pharma Managing Director Manoj Saxena said in a statement.
Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease in India.
Around seventy-four million people suffer from diabetes in the country and this figure is likely to increase to ninety-three million by 2030.
The number of people with diabetes in India is the second highest in the world, after China.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Include 4 hrs of physical activity, 8 hrs sleep in routine for optimal health, suggests study
Traffic noise can increase risk of cardiovascular disease: Study
Nearsightedness is at epidemic levels – and the problem begins in childhood
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
MUST WATCH
Latest Additions
ISRO releases ISSAR 2023 report on vulnerability of space assets to collisions
Hunasagi: MLA Bairati Basavaraj’s car overturned
No CM can remain absent for long, it’s against national interest: Delhi HC on Kejriwal
Cricket for the Blind: A Transformative Journey Empowering Visually Impaired Athletes
China lifts restrictions, gives all clear nod for Tesla cars as Musk lobbies hard in surprise visit to Beijing